#bioanalysis

🔬 𝐍𝐞𝐞𝐝 𝐝𝐞𝐞𝐩𝐞𝐫 𝐢𝐧𝐬𝐢𝐠𝐡𝐭 𝐢𝐧𝐭𝐨 𝐭𝐡𝐞 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐨𝐤𝐢𝐧𝐞𝐭𝐢𝐜𝐬 𝐚𝐧𝐝 𝐭𝐢𝐬𝐬𝐮𝐞 𝐝𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐨𝐟 𝐢𝐫𝐨𝐧 𝐟𝐨𝐫𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬? Understanding how iron-based therapies behave in the body is crucial—especially for improving safety, efficacy, and targeted delivery. We offer comparative pharmacokinetic and tissue distribution study for 🧪 Iron Sucrose Formulation 🧪 Ferric Carboxymaltose Formulation 💡 𝐖𝐡𝐲 𝐢𝐭 𝐦𝐚𝐭𝐭𝐞𝐫𝐬: Iron therapies often involve complex binding and transport mechanisms. To support your drug development goals, our validated ICP-MS methods unlock insights into total, transferrin-bound, and drug-bound iron in tissues and serum — helping you advance safer, more targeted therapies. Our methods offer high sensitivity, precision, and compliance—providing the data needed to make informed decisions in preclinical development. 📈 Partner with us to generate reliable, actionable insights that accelerate your path to market.

𝐁𝐢𝐠 𝐢𝐦𝐩𝐚𝐜𝐭, 𝐬𝐦𝐚𝐥𝐥 𝐯𝐨𝐥𝐮𝐦𝐞. That’s the advantage our team now delivers with the MSD QuickPlex SQ 120 - supporting exploratory to regulatory studies, all with lower sample volume requirements. From regulatory PK/TK and ADA studies to complex biomarker panels - our team is equipped and ready. Qualified for multi-plex detection of human cytokines in plasma and serum, this system is now at the heart of our bioanalytical services for Biologics research. Let’s advance together—connect with our experts today.

📢 𝐕𝐚𝐥𝐢𝐝𝐚𝐭𝐞𝐝 𝐈𝐧 𝐕𝐢𝐭𝐫𝐨 𝐏𝐨𝐭𝐚𝐬𝐬𝐢𝐮𝐦 𝐑𝐞𝐥𝐞𝐚𝐬𝐞 𝐀𝐬𝐬𝐚𝐲 𝐟𝐨𝐫 𝐋𝐢𝐩𝐨𝐬𝐨𝐦𝐚𝐥 𝐟𝐨𝐫𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬 𝐨𝐟 𝐀𝐦𝐩𝐡𝐨𝐭𝐞𝐫𝐢𝐜𝐢𝐧 𝐁 Eurofins Bioanalytical Services India offers a validated in vitro assay specifically tailored for liposomal Amphotericin B to quantify potassium release from red blood cells. The assay is optimized for 96-well plate format and leverages ICP-MS for potassium quantification achieving enhanced sensitivity and precision. This assay is ideally suited for Bio-IND applications requiring robust comparability between reference listed drug (RLD) and test formulations. 📩 For detailed assay insights or collaboration opportunities: [email protected]

𝐔𝐧𝐥𝐨𝐜𝐤 𝐑𝐚𝐩𝐢𝐝 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: 𝐁𝐢𝐨𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐘𝐨𝐮 𝐂𝐚𝐧 𝐓𝐫𝐮𝐬𝐭, 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐞𝐝 𝐅𝐚𝐬𝐭. Need timely and reliable bioanalytical data to drive your clinical trials forward? Our expert bioanalytical team understands the critical importance of speed. We deliver robust clinical sample analysis for Phase I-III studies, with typical data turnaround in just 72 hours from sample receipt. Leveraging advanced techniques like LC-MS/MS, Immunoanalytical methods, and HPLC, we provide sensitive and specific quantification of 𝐍𝐂𝐄𝐬, 𝐍𝐁𝐄𝐬, 𝐛𝐢𝐨𝐬𝐢𝐦𝐢𝐥𝐚𝐫𝐬, 𝐚𝐧𝐝 𝐠𝐞𝐧𝐞𝐫𝐢𝐜𝐬 across diverse matrices. Get actionable insights, faster. Contact us at 📧 [email protected].

In the fast-paced world of clinical trials, timely bioanalytical data is crucial. Eurofins Bioanalytical Services India delivers rapid, reliable results, empowering informed dose escalation decisions. We specialize in the robust bioanalysis of clinical samples, developing and validating sensitive and specific methods for NCEs, NBEs, biosimilars, and generics. Our cutting-edge techniques, including LC-MS/MS, Immunoanalytical, and HPLC, allow us to efficiently quantify analytes and metabolites in various matrices such as blood, serum, plasma, and urine for Phase I-III clinical trials. Our commitment to rapid turnaround times, with data typically available within 72 hours of sample receipt, ensures that you have the information you need, when you need it. Contact us today to discuss your clinical sample analysis needs and accelerate your drug development program – [email protected]

We are at the forefront of bioanalytical innovation, offering a wide range of services, seamlessly supporting both small and large molecule drug development. For small molecules: Fit-for-purpose bioanalytical methods are developed for discovery studies. GLP-compliant bioanalysis using fully validated bioanalytical methods are performed for studies conducted for regulatory submission. Our team has extensive expertise in developing sensitive methods on LC-MS/MS platforms, including analysis of multi-analytes, metabolites, pro-drugs, and photo/temperature sensitive and ex-vivo unstable compounds. Analytical methods for new chemical entities are routinely established and validated. For large molecules: our team has immense experience in developing and validating sensitive and specific analytical/immunogenicity methods for different modalities such as peptides, enzymes, monoclonal antibodies, vaccines, and gene therapy products. These immunoanalytical methods are designed and optimized specifically to the requirements of your product. We are committed to delivering the highest quality data that meets stringent regulatory requirements. We operate under robust quality systems and adhere to global regulatory guidelines, ensuring data integrity and reliability for your programs. Contact us for your specific requirement – [email protected]

From early discovery to clinical trials our biomarker bioanalysis services help advance your R&D. Our team has expertise to work on small and large molecules - develop and validate methods to analyze biomarkers in preclinical and clinical samples. Connect with us for your specific requirement 📧 [email protected]